GOLDSTEIN DOV A MD
Chief Financial Officer
GOLDSTEIN DOV A MD has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Apr 24, 2026.
On the most recent filing, GOLDSTEIN DOV A MD is listed as Chief Financial Officer at BioAge Labs, Inc. Inside the rolling window, GOLDSTEIN DOV A MD reported no open-market purchases and 1 open-market sale totaling $532K in BIOA.
Companies traded
Other insiders at BIOA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$532K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GOLDSTEIN DOV A MD made?
GOLDSTEIN DOV A MD has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does GOLDSTEIN DOV A MD trade?
GOLDSTEIN DOV A MD has filed SEC Form 4 disclosures for 1 company, including BIOA.
When was GOLDSTEIN DOV A MD's most recent SEC Form 4 filing?
GOLDSTEIN DOV A MD's most recent SEC Form 4 filing on Tracefour is dated Apr 24, 2026.
What is GOLDSTEIN DOV A MD's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, GOLDSTEIN DOV A MD is listed as Chief Financial Officer.
What is GOLDSTEIN DOV A MD's total buy and sell value in the current window?
Inside the rolling retention window, GOLDSTEIN DOV A MD bought $0 and sold $532K based on SEC Form 4 filings.
What was GOLDSTEIN DOV A MD's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 27,000 BIOA shares on 2026-01-13, worth $532K, per SEC Form 4 filings.